Structural analysis of isosteviol and related compounds as DNA polymerase and DNA topoisomerase inhibitors

被引:89
作者
Mizushina, Y [1 ]
Akihisa, T
Ukiya, M
Hamasaki, Y
Murakami-Nakai, C
Kuriyama, I
Takeuchi, T
Sugawara, F
Yoshida, H
机构
[1] Kobe Gakuin Univ, Dept Nutr Sci, Lab Food & Nutr Sci, Nishi Ku, Kobe, Hyogo 6512180, Japan
[2] Kobe Gakuin Univ, High Technol Res Ctr, Nishi Ku, Kobe, Hyogo 6512180, Japan
[3] Nihon Univ, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan
[4] Sci Univ Tokyo, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan
关键词
isosteviol; DNA polymerase; DNA topoisomerase; enzyme inhibitor; cytotoxicity; anti-inflammation;
D O I
10.1016/j.lfs.2005.03.022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Isosteviol (ent-16-ketobeyeran-19-oic acid) is a hydrolysis product of stevioside, which is a natural sweetener produced in the leaves of Stevia rebaudiana (Bertoni) Bertoni. In this report, we prepared isosteviol and related compounds from stevioside by microbial transformation and chemical conversion and assayed the inhibitory activities toward DNA metabolic enzymes and human cancer cell growth. Among twelve compounds obtained, only isosteviol (compound 3) potently inhibited both mammalian DNA polymerases (pols) and human DNA topoisomerase II (topo II), and IC50 value for pol alpha was 64.0 mu M. This compound had no inhibitory effect on higher plant (cauliflower) pols, prokaryotic pols, human topo I, and DNA metabolic enzymes such as human telomerase, T7 RNA polymerase, and bovine deoxyribonuclease I. With pol alpha, isosteviol acted non-competitively with the DNA template-primer and nucleotide substrate. Isosteviol prevented the growth of human cancer cells, with LD50 values of 84-167 mu M, and 500 mu g of the compound caused a marked reduction in TPA (12-O-tetradecanoylphorbol-13-acetate)-induced inflammation (inhibitory effect, 53.0%). The relationship between the structure of stevioside-based compounds and these activities were discussed. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:2127 / 2140
页数:14
相关论文
共 30 条
  • [11] SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER
    KIM, NW
    PIATYSZEK, MA
    PROWSE, KR
    HARLEY, CB
    WEST, MD
    HO, PLC
    COVIELLO, GM
    WRIGHT, WE
    WEINRICH, SL
    SHAY, JW
    [J]. SCIENCE, 1994, 266 (5193) : 2011 - 2015
  • [12] King AYC, 2002, SIGHTS OF CONTESTATION: LOCALISM, GLOBALISM AND CULTURAL PRODUCTION IN ASIA AND THE PACIFIC, P1
  • [13] LU BC, 1991, J BIOL CHEM, V266, P21060
  • [14] Novel anti-inflammatory compounds from Myrsine seguinii, terpeno-benzoic acids, are inhibitors of mammalian DNA polymerases
    Mizushina, Y
    Miyazaki, S
    Ohta, K
    Hirota, M
    Sakaguchi, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2000, 1475 (01): : 1 - 4
  • [15] Some anti-chronic inflammatory compounds are DNA polymerase λ-specific inhibitors
    Mizushina, Y
    Hirota, M
    Murakami, C
    Ishidoh, T
    Kamisuki, S
    Shimazaki, N
    Takemura, M
    Perpelescu, M
    Suzuki, M
    Yoshida, H
    Sugawara, F
    Koiwai, O
    Sakaguchi, K
    [J]. BIOCHEMICAL PHARMACOLOGY, 2003, 66 (10) : 1935 - 1944
  • [16] The inhibitory action of fatty acids on DNA polymerase beta
    Mizushina, Y
    Yoshida, S
    Matsukage, A
    Sakaguchi, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1997, 1336 (03): : 509 - 521
  • [17] Fatty acids selectively inhibit eukaryotic DNA polymerase activities in vitro
    Mizushina, Y
    Tanaka, N
    Yagi, H
    Kurosawa, T
    Onoue, M
    Seto, H
    Horie, T
    Aoyagi, N
    Yamaoka, M
    Matsukage, A
    Yoshida, S
    Sakaguchi, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1996, 1308 (03): : 256 - 262
  • [19] Novel anti-inflammatory compounds from Rubus sieboldii, triterpenoids, are inhibitors of mammalian DNA polymerases
    Murakami, C
    Ishijima, K
    Hirota, M
    Sakaguchi, K
    Yoshida, H
    Mizushina, Y
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2002, 1596 (02): : 193 - 200
  • [20] Nakamura Y, 1998, CANCER RES, V58, P4832